Haisam Abid, MBBS

Haisam Abid practices at Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health.

Haisam Abid's NPI, 1578083184, was assigned on June 23, 2017. Haisam Abid holds Wisconsin license 73025.

Haisam Abid's primary practice is Froedtert Hospital, at 9200 W Wisconsin Ave, Milwaukee, WI 53226 in Milwaukee County. The practice phone is (414) 805-3000.

Haisam Abid's primary practice is Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Haisam Abid practices. Vendor and product names are available with a free account.

Hospitalist is Haisam Abid's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Haisam Abid is licensed in Wisconsin.

CMS data shows 158 Medicare services from Haisam Abid across 2 procedure codes in 2024, for 58 Medicare patients. Medicare paid $9,508 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 58 Medicare patients who saw Haisam Abid in 2024. The largest group is under 65, with 22 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 52% are also on Medicaid. Their average risk score is 4.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Haisam Abid's median patient age at 72, with 40% women.

In 2024, Haisam Abid wrote 116 Medicare Part D claims for 55 patients. 84% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $618 in total drug cost. In 2020, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Haisam Abid for performance year 2024, reported as part of a group.

CMS Open Payments shows 3 general payments to Haisam Abid from 3 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $91.